Search Results - "PEREZ DE OTEYZA, Jaime"

Analysis of economic and social costs of adverse events associated with blood transfusions in Spain by Ribed-Sánchez, Borja, González-Gaya, Cristina, Varea-Díaz, Sara, Corbacho-Fabregat, Carlos, Bule-Farto, Isabel, Pérez de-Oteyza, Jaime

“…To calculate, for the first time, the direct and social costs of transfusion-related adverse events in order to include them in the National Healthcare…”
Get full text

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial by RIBERA, Josep-Maria, ORIOL, Albert, MARTIN-REINA, Victoria, SARRA, Josep, PARODY, Ricardo, PEREZ DE OTEYZA, Jaime, BUREO, Encarna, VERNAL, Maria-Teresa, GONZALEZ, Marcos, VIDRIALES, Belén, BRUNET, Salut, ESTEVE, Jordi, DEL POTRO, Eloy, RIVAS, Concepción, MORENO, Maria-José, TORMO, Mar

“…Imatinib, given concurrently or alternating with chemotherapy, has improved the response and survival of patients with Philadelphia chromosome-positive acute…”
Get full text

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms by Steensma, David P., Wermke, Martin, Klimek, Virginia M., Greenberg, Peter L., Font, Patricia, Komrokji, Rami S., Yang, Jay, Brunner, Andrew M., Carraway, Hetty E., Ades, Lionel, Al-Kali, Aref, Alonso-Dominguez, Juan M., Alfonso-Piérola, Ana, Coombs, Catherine C., Deeg, H. Joachim, Flinn, Ian, Foran, James M., Garcia-Manero, Guillermo, Maris, Michael B., McMasters, Malgorzata, Micol, Jean-Baptiste, De Oteyza, Jaime Perez, Thol, Felicitas, Wang, Eunice S., Watts, Justin M., Taylor, Justin, Stone, Richard, Gourineni, Vikram, Marino, Alyssa J., Yao, Huilan, Destenaves, Benoit, Yuan, Xiaobin, Yu, Kun, Dar, Sara, Ohanjanian, Lernik, Kuida, Keisuke, Xiao, Jianjun, Scholz, Catherine, Gualberto, Antonio, Platzbecker, Uwe

“…We conducted a phase I clinical trial of H3B-8800, an oral small molecule that binds Splicing Factor 3B1 (SF3B1), in patients with MDS, CMML, or AML. Among 84…”
Get full text

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM by Mateos, María-Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique-M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Martín Ramos, María-Luisa, Oriol, Albert, Bargay, Joan, Bengoechea, Enrique, González, Yolanda, Pérez de Oteyza, Jaime, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Paiva, Bruno, Cedena, María-Teresa, Puig, Noemí, Bladé, Joan, Lahuerta, Juan-José, San-Miguel, Jesús

“…Bortezomib plus melphalan and prednisone (VMP) and lenalidomide plus low-dose dexamethasone (Rd) are 2 standards of care for elderly untreated multiple myeloma…”
Get full text

Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas by Sancho, Juan‐Manuel, Navarro, Belén, Soler Campos, Joan Alfons, Oteyza, Jaime Pérez, Barrenetxea Lekue, Cristina, Bregni, Marco, Grasso Cicala, Silvina, Spione, Mario, Mombiedro, Cristina, Soler, Begoña, Zinzani, Pier Luigi

“…Background and objective Few treatment options exist for patients with relapsed/refractory (R/R) B‐cell non‐Hodgkin lymphoma (NHL) who fail first‐ and…”
Get full text

Recommendations on the use of azole antifungals in hematology-oncology patients by Azanza, J R, Mensa, J, Barberán, J, Vázquez, L, Pérez de Oteyza, J, Kwon, M, Yáñez, L, Aguado, J M, Cubillo Gracian, A, Solano, C, Ruiz Camps, I, Fortún, J, Salavert Lletí, M, Gudiol, C, Olave Rubio, T, García-Vidal, C, Rovira Tarrats, M, Suárez-Lledó Grande, M, González-Sierra, P, Dueñas Gutiérrez, C

“…The administration of antifungals for therapeutic and, especially, prophylactic purposes is virtually a constant in patients requiring hematology-oncology…”
Get full text

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role by Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Martín-Calvo, Nerea, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Paiva, Bruno, Puig, Noemí, Oriol, Albert, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.

“…Although survival of elderly myeloma patients has significantly improved there is still a subset of patients who, despite being fit and achieving optimal…”
Get full text

Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine by Bennett, Teresa A, Montesinos, Pau, Moscardo, Federico, Martinez-Cuadron, David, Martinez, Joaquin, Sierra, Jorge, García, Raimundo, de Oteyza, Jaime Perez, Fernandez, Pascual, Serrano, Josefina, Fernandez, Angeles, Herrera, Pilar, Gonzalez, Ataulfo, Bethancourt, Concepcion, Rodriguez-Macias, Gabriela, Alonso, Arancha, Vera, Juan A, Navas, Begoña, Lavilla, Esperanza, Lopez, Juan A, Jimenez, Santiago, Simiele, Adriana, Vidriales, Belen, Gonzalez, Bernardo J, Burgaleta, Carmen, Hernandez Rivas, Jose A, Mascuñano, Raul Cordoba, Bautista, Guiomar, Perez Simon, Jose A, Fuente, Adolfo de la, Rayón, Consolación, Troconiz, Iñaki F, Janda, Alvaro, Bosanquet, Andrew G, Hernandez-Campo, Pilar, Primo, Daniel, Lopez, Rocio, Liebana, Belen, Rojas, Jose L, Gorrochategui, Julian, Sanz, Miguel A, Ballesteros, Joan

“…Micro-Abstract We have estimated the pharmacological sensitivity and synergism of 125 individual patient samples for all drugs and combination treatments for…”
Get full text

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia by Megías-Vericat, Juan Eduardo, Martínez-Cuadrón, David, López, Joaquín Martínez, Bergua, Juan Miguel, Tormo, Mar, Serrano, Josefina, González, Ataulfo, de Oteyza, Jaime Pérez, Vives, Susana, Vidriales, Belén, Herrera, Pilar, Vera, Juan Antonio, Martínez, Aurelio López, de la Fuente, Adolfo, Amador, Ma Lourdes, Hernández-Rivas, José-Ángel, Fernández, Ma Ángeles, Cerveró, Carlos Javier, Morillo, Daniel, Campo, Pilar Hernández, Gorrochategui, Julián, Primo, Daniel, Rojas, José Luis, Guenova, Margarita, Ballesteros, Joan, Sanz, Miguel, Montesinos, Pau

“…Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has…”
Get full text

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma by Gordon, Leo I, Kaplan, Jason B, Popat, Rakesh, Burris, 3rd, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, Ian, Radford, John A, Pérez de Oteyza, Jaime, Zinzani, Pier Luigi, Iyer, Swaminathan, Townsend, William, Karmali, Reem, Miao, Harry, Proscurshim, Igor, Wang, Shining, Wu, Yujun, Stumpo, Kate, Shou, Yaping, Carpio, Cecilia, Bosch, Francesc

“…TAK-659 is an investigational, dual SYK/FLT3 inhibitor with preclinical activity in B-cell malignancy models. This first-in-human, dose-escalation/expansion…”
Get full text

Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients by Puertas, Borja, González-Calle, Verónica, Sureda, Anna, Moreno, María José, Oriol, Albert, González, Esther, Rosiñol, Laura, López, Jordi, Escalante, Fernando, Martínez-Lopez, Joaquín, Carrillo, Estrella, Clavero, Esther, Ríos-Tamayo, Rafael, Rey-Bua, Beatriz, González-Rodríguez, Ana Pilar, Dourdil, Victoria, De Arriba, Felipe, González, Sonia, Pérez-de-Oteyza, Jaime, Hernández, Miguel T, García-Mateo, Aránzazu, Bargay, Joan, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F, Ocio, Enrique M, Mateos, María-Victoria

“…In this randomized phase 2 study (GEM-KyCyDex), the combination of weekly carfilzomib 70 mg/m2, cyclophosphamide and dexamethasone was compared to carfilzomib…”
Get full text

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM) by González-Rincón, Julia, Garcia-Vela, José A, Gómez, Sagrario, Fernández-Cuevas, Belén, Nova-Gurumeta, Sara, Pérez-Sanz, Nuria, Alcoceba, Miguel, González, Marcos, Anguita, Eduardo, López-Jiménez, Javier, González-Barca, Eva, Yáñez, Lucrecia, Pérez-Persona, Ernesto, de la Serna, Javier, Fernández-Zarzoso, Miguel, Deben, Guillermo, Peñalver, Francisco J, Fernández, María C, de Oteyza, Jaime Pérez, Andreu, M Ángeles, Ruíz-Guinaldo, M Ángeles, Paz-Arias, Raquel, García-Malo, M Dolores, Recasens, Valle, Collado, Rosa, Córdoba, Raúl, Navarro-Matilla, Belén, Sánchez-Beato, Margarita, García-Marco, José A

“…Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in Western countries and is notable for its variable clinical course. This variability is…”
Get full text

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study by Bastos-Oreiro, Mariana, Gutierrez, Antonio, Cabero, Almudena, López, Javier, Villafuerte, Paola, Jiménez-Ubieto, Ana, de Oña, Raquel, De la Fuente, Adolfo, Navarro, Belén, Peñalver, Javier, Martínez, Pilar, Alonso, Carmen, Infante, María, Córdoba, Raúl, Perez-Montero, Blanca, Pérez de Oteyza, Jaime, González de Villambrosio, Sonia, Fernández-Caldas, Paula, Del Campo, Raquel, García Belmonte, Daniel, Diaz-Gálvez, Javier, Salar, Antonio, Sancho, Juan-Manuel

“…Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) and R-bendamustine (R-B) are the most common frontline treatment strategies for…”
Get full text

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing by Ruiz-Heredia, Yanira, Sánchez-Vega, Beatriz, Onecha, Esther, Barrio, Santiago, Alonso, Rafael, Martínez-Ávila, Jose Carlos, Cuenca, Isabel, Agirre, Xabier, Braggio, Esteban, Hernández, Miguel-T, Martínez, Rafael, Rosiñol, Laura, Gutierrez, Norma, Martin-Ramos, Marisa, Ocio, Enrique M, Echeveste, María-Asunción, de Oteyza, Jaime Pérez, Oriol, Albert, Bargay, Joan, Gironella, Mercedes, Ayala, Rosa, Bladé, Joan, Mateos, María-Victoria, Kortum, Klaus M, Stewart, Keith, García-Sanz, Ramón, Miguel, Jesús San, Lahuerta, Juan José, Martinez-Lopez, Joaquín

Get full text

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study by Van Den Neste, Eric, Cazin, Bruno, Janssens, Ann, González-Barca, Eva, Terol, María José, Levy, Vincent, Pérez de Oteyza, Jaime, Zachee, Pierre, Saunders, Andrew, de Frias, Mercè, Campàs, Clara

“…Purpose Acadesine has shown in vitro to selectively induce apoptosis in B cells from chronic lymphocytic leukemia (CLL) patients. We conducted a phase I/II…”
Get full text

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role by Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Martín-Calvo, Nerea, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Paiva, Bruno, Puig, Noemí, Oriol, Albert, Bladé, Joan, Lahuerta, Juan José, Miguel, Jesús F. San

“…Following the publication of this article, the author notes that the following information was missed from the acknowledgments section:…”
Get full text

Genetic Subtyping Using Whole Exome Sequencing across Large B Cell Lymphoma Entities in a Series of 109 DLBCL and Plasmablastic Lymphoma Cases by Montes-Moreno, Santiago, Avendaño, Aitana, Gonzalez De Villambrosia, Sonia, Rodriguez-Merino, Laura, Morata, Jordi, Tonda, Raul, Carrillo-Cruz, Estrella, Grande, Carlos, Roncero, Jose Maria, Perez De Oteyza, Jaime, Nicolas, Concepcion, Rey Búa, Beatriz, Abrisqueta, Pau, Gutierrez, Antonio, Ramirez, Angel, Martin Garcia-Sancho, Alejandro, Gonzalez Barca, Eva Maria

“…Background: Diffuse Large B Cell Lymphomas are still a significantly heterogeneous disease with few molecularly defined entities. Recently genomic based…”
Get full text

Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature by Rodríguez-Otero, Paula, Mateos, María Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique M., Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C., Bargay, Joan, Bengoechea, Enrique, González, Yolanda, de Oteyza, Jaime Pérez, Gironella, Mercedes, Nuñez-Córdoba, Jorge M., Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Palomera, Luis, de Arriba, Felipe, Cedena, María Teresa, Puig, Noemí, Oriol, Albert, Paiva, Bruno, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F.

“…Disease control at 5 years would be a desirable endpoint for elderly multiple myeloma (MM) patients, but biomarkers predicting this are not defined. Therefore,…”
Get full text

Rituximab Maintenance after R-Bendamustine or R-CHOP in First-Line Treatment of Low-Grade Follicular Lymphoma: A Multicentre, Retrospective Study of the Spanih Group Geltamo by Bastos-Oreiro, Mariana, Gutierrez, Antonio, Cabero Martínez, Almudena, López Jiménez, Javier, Villafuerte Gutierrez, Paola Sandra, Jimenez-Ubieto, Ana, De La Fuente, Adolfo, Navarro, Belén, Infante, Maria Stefania, Cordoba, Raul, Perez De Oteyza, Jaime, González de Villambrosia, Sonia, Del Campo, Raquel, Garcia, Daniel, Salar, Antonio, Sancho, Juan-Manuel

Get full text

Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study by Martino, R, Perea, G, Caballero, MD, Mateos, MV, Ribera, JM, de Oteyza, JP, Arranz, R, Terol, MJ, Sierra, J, San Miguel, JF

“…Servei d'Hematologia Clinica, Hospital de la Santa Creu i Sant Pau, Av. Sant Antoni M(a) Claret 167, 08025 Barcelona, Spain. rmartino@hsp.santpau.es BACKGROUND…”
Get full text